Sessler F M, Liu W, Kirifides M L, Mouradian R D, Lin R C, Waterhouse B D
Department of Anatomy and Neurobiology, Medical College of Pennsylvania, Philadelphia 19102, USA.
Brain Res. 1995 Mar 27;675(1-2):171-82. doi: 10.1016/0006-8993(95)00060-4.
Previous in vivo studies have shown that microiontophoretic application of norepinephrine (NE) and isoproterenol (ISO) can enhance gamma-aminobutyric acid (GABA)-induced depressant responses of rat somatosensory cortical neurons. In the present investigation we have examined the transmembrane electrophysiological events which are associated with interactions between NE and GABA in layer V pyramidal neurons of rat barrel field cortex. Intracellular recordings were made from electrophysiologically identified cells in a superfused cortical tissue slice preparation before, during and after bath or microdrop application of GABA, NE and ISO, alone or in combination. GABA application produced a small depolarization from resting membrane potential associated with a reduction (22%) in input resistance. NE and ISO (10-100 microM) also produced in some cases small membrane depolarizations (1-4 mV) but little concomitant changes in input resistance. Simultaneous application of NE with GABA potentiated amino acid-induced changes in input resistance in 4 cases and antagonized (n = 4) or had no effect (n = 4) on GABA-associated membrane events in 8 other cases. When the alpha-blocker, phentolamine (20 microM), was added to the medium, NE-induced enhancement of the GABA response was observed in 3 of 5 cases (60%), suggesting both, a beta-adrenergic mediation and a possible alpha-receptor masking of this noradrenergic-potentiating action. Consistent with this interpretation was the finding that the beta-agonist, ISO (10-100 microM), produced net increases in GABA-induced input resistance changes in 64% of cases tested (9 of 14). The potentiating effect of NE and ISO was mimicked by the adenyl cyclase activator, forskolin (n = 2), and a membrane permeant analog of cyclic-AMP, 8-bromo-cyclic AMP (n = 3); and could also be demonstrated when the GABAA agonist muscimol (0.5-1 microM) was substituted for GABA. The reversal potential for GABA and GABA + NE remained the same. These findings suggest that previous demonstrations of NE-potentiating effects on GABA inhibition may be mediated by beta-receptor/cyclic-AMP-linked actions on mechanisms which regulate GABAA receptor-induced membrane conductance changes.
以往的体内研究表明,通过微离子电泳施加去甲肾上腺素(NE)和异丙肾上腺素(ISO)可增强γ-氨基丁酸(GABA)诱导的大鼠体感皮层神经元的抑制反应。在本研究中,我们检测了与大鼠桶状皮层V层锥体神经元中NE和GABA相互作用相关的跨膜电生理事件。在单独或联合浴用或微量滴注GABA、NE和ISO之前、期间和之后,从灌注皮层组织切片制备中电生理鉴定的细胞进行细胞内记录。施加GABA会使静息膜电位产生小的去极化,同时输入电阻降低(22%)。NE和ISO(10 - 100微摩尔)在某些情况下也会使膜产生小的去极化(1 - 4毫伏),但输入电阻几乎没有伴随变化。NE与GABA同时施加时,在4例中增强了氨基酸诱导的输入电阻变化,在另外8例中拮抗(n = 4)或对GABA相关的膜事件无影响(n = 4)。当向培养基中加入α-阻滞剂酚妥拉明(20微摩尔)时,在5例中的3例(60%)观察到NE诱导的GABA反应增强,这表明存在β-肾上腺素能介导以及这种去甲肾上腺素能增强作用可能存在α-受体掩盖现象。与此解释一致的是,β-激动剂ISO(10 - 100微摩尔)在64%的测试病例(14例中的9例)中使GABA诱导的输入电阻变化净增加。NE和ISO的增强作用被腺苷酸环化酶激活剂福斯可林(n = 2)和环磷酸腺苷的膜通透性类似物8-溴环磷酸腺苷(n = 3)模拟;当用GABAA激动剂蝇蕈醇(0.5 - 1微摩尔)替代GABA时也能证明这种增强作用。GABA以及GABA + NE的反转电位保持不变。这些发现表明,先前关于NE对GABA抑制作用增强的证明可能是由β-受体/环磷酸腺苷相关作用介导的,这些作用作用于调节GABAA受体诱导的膜电导变化的机制。